Beta-O2’s ßAir Bio-artificial Adrenal Device Shows Potential to Treat Stress-related Disorders

Israeli biomedical firm Beta-O2 announced the results of a series of pre-clinical studies demonstrating that the company’s ßAir Bio-artificial Adrenal device could offer a treatment for adrenocortical More...

First Patient Successfully Implanted with Beta-02 ßAir Bio-Artificial Pancreas

Beta-O2 technologies,  an Israeli bio-medical company which develops a proprietary implantable bio-reactor, the ßAir, for the treatment and potential cure of type 1 diabetes announced that the first patient More...